QQ客服 官方微博 反馈留言

	Effects of PON1 Gene Promoter DNA Methylation and Genetic Variations on the Clinical Outcomes of Dual Antiplatelet Therapy for Patients Undergoing Percutaneous Coronary Intervention
	Lei, HP; Yu, XY; Wu, H; Kang, YH; Zhong, WP; Cai, LY; Zhang, MZ; Chen, JY; Mai, LP; Ding, QS
刊名	CLINICAL PHARMACOKINETICS
	2018
卷号	Vol.57 No.7页码:817-829
ISSN号	0312-5963;1179-1926
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5460324
专题	湖南大学
作者单位	1.Guangdong Acad Med Sci, Guangdong Prov Key Lab Coronary Heart Dis Prevent, Guangdong Cardiovasc Inst, Guangdong Gen Hosp, 96 Dongchuan Rd,Weilun Bldg, Guangzhou 510080, Guangdong, Peoples R China 2.South China Univ Technol, Sch Med, Guangzhou 510080, Guangdong, Peoples R China 3.Guangzhou Med Univ, Sch Pharmaceut Sci, Guangzhou 511436, Guangdong, Peoples R China 4.Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou 510020, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Lei, HP,Yu, XY,Wu, H,et al. Effects of PON1 Gene Promoter DNA Methylation and Genetic Variations on the Clinical Outcomes of Dual Antiplatelet Therapy for Patients Undergoing Percutaneous Coronary Intervention[J]. CLINICAL PHARMACOKINETICS,2018,Vol.57 No.7:817-829.
APA	Lei, HP.,Yu, XY.,Wu, H.,Kang, YH.,Zhong, WP.,...&Ding, QS.(2018).Effects of PON1 Gene Promoter DNA Methylation and Genetic Variations on the Clinical Outcomes of Dual Antiplatelet Therapy for Patients Undergoing Percutaneous Coronary Intervention.CLINICAL PHARMACOKINETICS,Vol.57 No.7,817-829.
MLA	Lei, HP,et al."Effects of PON1 Gene Promoter DNA Methylation and Genetic Variations on the Clinical Outcomes of Dual Antiplatelet Therapy for Patients Undergoing Percutaneous Coronary Intervention".CLINICAL PHARMACOKINETICS Vol.57 No.7(2018):817-829.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。